MYELOMA
Clinical trials for MYELOMA explained in plain language.
Never miss a new study
Get alerted when new MYELOMA trials appear
Sign up with your email to follow new studies for MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study tests a new type of cell therapy for people with certain cancers (lymphoma, myeloma, and solid tumors like kidney cancer and sarcoma) that have returned or not responded to standard treatments. The therapy uses the patient's own T cells, which are modified …
Matched conditions: MYELOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New study aims to make allergy testing safer for cancer patients on biologics
Knowledge-focused Not yet recruitingThis study involves 70 patients with various cancers who are receiving biotherapy drugs. Researchers want to find the highest safe concentration of these drugs to use in skin allergy tests, so they can better diagnose allergic reactions. The goal is to create clear guidelines for…
Matched conditions: MYELOMA
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC
-
UK study checks Real-Life success of myeloma drug combo
Knowledge-focused Not yet recruitingThis study will look back at medical records of 300 UK patients with newly diagnosed multiple myeloma who cannot have a stem cell transplant. All patients received a three-drug treatment called DRd (daratumumab, lenalidomide, and dexamethasone) in regular clinics, not in a clinic…
Matched conditions: MYELOMA
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Knowledge-focused
Last updated May 04, 2026 16:22 UTC